USD 0.0
(0.0%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2006 | 2005 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | 1.75 Million | -1000.00 | - | -765.19 Thousand | -1.85 Million |
Net Income | - | 1.22 Million | -1000.00 | - | -11.94 Million | -6.04 Million |
Depreciation & Amortization | - | 311.71 Thousand | - | - | 2.27 Million | 2.66 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | 220.22 Thousand | - | - | 847.97 Thousand | -430.71 Thousand |
Other non-cash items | - | 772.69 Thousand | - | - | 8.05 Million | 1.95 Million |
Investing Cash Flow | - | -5.79 Million | -151.08 Thousand | - | -4457.00 | -469.91 Thousand |
Investments in PPE | - | -2.48 Million | - | - | -4457.00 | -34.98 Thousand |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | -3.3 Million | -151.08 Thousand | - | - | -434.92 Thousand |
Financing Cash Flow | - | 4.06 Million | 152.08 Thousand | - | 730.02 Thousand | 2.37 Million |
Debt repayment | - | -4.21 Million | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | 476.1 Thousand | 127.09 Thousand |
Other Financing Activities | - | -152.08 Thousand | 152.08 Thousand | - | 253.92 Thousand | 2.24 Million |
Accounts receivables | - | -433.36 Thousand | - | - | - | - |
Accounts payables | - | 284.09 Thousand | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | 369.49 Thousand | - | - | - | - |
Cash at beginning of period | 31.61 Thousand | 10 Thousand | - | - | 66.06 Thousand | 19.52 Thousand |
Cash at end of period | 31.61 Thousand | 31.61 Thousand | - | - | 26.43 Thousand | 66.06 Thousand |
Capital Expenditure | - | -2.48 Million | - | - | -4457.00 | -34.98 Thousand |
Effect of forex changes on cash | - | -1.00 | - | - | - | - |
Net cash flow / Change in cash | - | 21.61 Thousand | - | - | -39.62 Thousand | 46.53 Thousand |
Free Cash Flow | - | -735.75 Thousand | -1000.00 | - | -769.65 Thousand | -1.89 Million |
Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q3 | 2022 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | - | 387 Thousand | - | 915.46 Thousand | 103.91 Thousand |
Depreciation & Amortization | - | - | 100.93 Thousand | - | - | 100.93 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -158.11 Thousand | - | 92.21 Thousand | -351.94 Thousand |
Other non-cash items | - | - | 351.51 Thousand | - | -156.01 Thousand | 451.7 Thousand |
Investing Cash Flow | - | - | - | - | - | -73.98 Thousand |
Investments in PPE | - | - | - | - | - | -73.98 Thousand |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | -173.77 Thousand | - | -200.26 Thousand | 243.62 Thousand |
Debt repayment | - | - | -6174.00 | - | -118.35 Thousand | -243.62 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | -167.59 Thousand | - | -81.91 Thousand | - |
Accounts receivables | - | - | -39.9 Thousand | - | 103.75 Thousand | 64.57 Thousand |
Accounts payables | - | - | -109.74 Thousand | - | 16.81 Thousand | -39.4 Thousand |
Inventory | - | - | - | - | 35.44 Thousand | -275 Thousand |
Other working capital | - | - | -8469.00 | - | -63.79 Thousand | -102.11 Thousand |
Cash at beginning of period | - | 1.54 Million | 835.31 Thousand | 31.61 Thousand | 27.18 Thousand | 4641.00 |
Cash at end of period | - | 1.54 Million | 1.54 Million | 31.61 Thousand | 835.31 Thousand | 27.18 Thousand |
Capital Expenditure | - | - | - | - | - | -73.98 Thousand |
Effect of forex changes on cash | - | - | - | - | - | -1.00 |
Net cash flow / Change in cash | - | - | 705.05 Thousand | - | 808.12 Thousand | 22.54 Thousand |
Free Cash Flow | - | - | 329.82 Thousand | - | 1 Million | -221.08 Thousand |
SLSDF
CARCY
FESA3
DIABIO
GENPHARMA
GATE